Univercells Technologies provides innovative biomanufacturing technologies to help customers achieve cost-effective viral production from R&D to commercial scales. Leveraging the strengths of process intensification and chaining, the technology portfolio delivers increased performance with minimized footprint and costs.

We build upon years of expertise and capitalize on technology developed by Univercells and vetted by world leaders to deliver the next evolution of biomanufacturing technologies.

Incorporated in Belgium in 2020, Univercells Technologies is now a part of Donaldson Company.

The next evolution of biomanufacturing